FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/045151 [Registered on: 01/09/2022] Trial Registered Prospectively
Last Modified On: 31/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A study to evaluate the effect of application of Ksheera bala oil on head and foot massage for sleeplessness in Menopausal women  
Scientific Title of Study   An Open label Single-arm study to Evaluate the Effect of Siropicu and Padabhyanga with Ksirabala taila in the management of Insomnia in Menopausal Women 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Parvathy B 
Designation  Second year PG Scholar 
Affiliation  Amrita School of Ayurveda 
Address  Department Of Stri Roga And Prasuti Tantra(Gynaecology and Obstetrics) Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri clappana P.O.

Kollam
KERALA
690525
India 
Phone  7025060023  
Fax    
Email  amayp3pts20027@ay.amrita.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shaithya Raj  
Designation  Associate Professor  
Affiliation  Amrita School of Ayurveda 
Address  Department Of Stri Roga And Prasuti Tantra(Gynaecology and Obstetrics) Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri Clappana P.O.

Kollam
KERALA
690525
India 
Phone  9495434862  
Fax    
Email  shaithyaraj@ay.amrita.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Parvathy B 
Designation  Second year PG Scholar 
Affiliation  Amrita School of Ayurveda 
Address  Department Of Stri Roga And Prasuti Tantra(Gynaecology and Obstetrics) Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri clappana P.O.

Kollam
KERALA
690525
India 
Phone  7025060023  
Fax    
Email  amayp3pts20027@ay.amrita.edu  
 
Source of Monetary or Material Support  
Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O. Kerala, India – 690 525. 
 
Primary Sponsor  
Name  Dr Parvathy B 
Address  Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O. Kerala, India – 690 525. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parvathy B  Amrita Ayurveda Hospital  (OPD NO-5) and IPD of Department of Stri Roga And Prasuti Tantra (Gynaecology and Obstetrics), Amrita School of Ayurveda Amritapuri Amrita Viswha Vidyapeetham India Kollam KERALA
Kollam
KERALA 
7025060023

amayp3pts20027@ay.amrita.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Amrita Institute of Medical Science, Kochi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N951||Menopausal and female climactericstates. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-SiraHpicuH (Procedure Reference: (Su. Sa. 4/43), Procedure details: After taking informed consent, the procedure of siropicu and pada abhyanga will be explained and proper training will be given to the patient and bystander. The patient will also receive a pamphlet and video demonstrating the detailed procedure of siropicu and pada abhyanga. The patient is advised to do siropicu 1 hour before sleep with a duration of 30 minutes for 7 days and after the procedure, wipe it clearly with a dry cloth. Patients will be advised to report on the 8th day, the assessment )
(1) Medicine Name: Ksirabala taila, Reference: (Sahasrayoga taila prakarana), Route: Topical, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Duration: 7 Days
2Intervention ArmProcedure-EkA~gga (Procedure Reference: (Su. Ci. 24/70), Procedure details: After taking informed consent, the procedure of Siropicu and Padabhyanga will be explained and proper training will be given to the patient and bystander. A pamphlet and video demonstrating the detailed procedure of Siropicu and Padabhyanga will also be given to the patient.Patient is advised to do Padabhyanga on each foot for a minimum of 5 minutes twice daily for 15 days and advised to take rest for 10 minutes after the procedure and wipe it clearly with a dry cloth.Patient will be advised to )
(1) Medicine Name: Ksirabala taila, Reference: (Sahsrayoga taila prakarana), Route: Topical, Dosage Form: Taila, Dose: 10(ml), Frequency: bd, Duration: 15 Days
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  1. Amenorrhea (greater than or equal to 12 consecutive months)
2. Age group (40 – 60 yrs)
3. Insomnia severity index score (greater than or equal to 8)

 
 
ExclusionCriteria 
Details  1. Hypertension
2. Chronic illness where Insomnia is seen as a complication ( Parkinson’s disease, Epilepsy)
3. Any known case of Malignancy
4. Anxiety and Depression (Hospital Anxiety and Depression Scale score greater than 7)
5. Women taking any medication influencing sleep
6. Known case of other Sleep disorders such as Restless leg syndrome and obstructive sleep apnea
7. Known case of Sinusitis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 

1. Severity of Sleep: Insomnia severity index.
2. Quality of sleep: Pitts burg sleep quality index (PSQI scale)

 
At base line 1st Day (D1)
8th Day (D8)
16th Day (D16)  
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   12/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [amayp3pts20027@ay.amrita.edu].

  6. For how long will this data be available start date provided 08-03-2024 and end date provided 08-10-2029?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   BACKGROUND Insomnia is characterized by long sleep latency, frequent awakening or prolonged period of wakefulness during the sleep period, or even frequent transient arousal. Insomnia that occurs for at least three nights a week for three consecutive months is considered chronic and results in social, occupational, and behavioral distress. Women complain more frequently of insomnia than men and insomnia increases with age. The prevalence of sleep disturbances in Postmenopausal women is about 28% - 63%. Menopausal Insomnia is associated with multiple adverse effects on quality of life, decreased work productivity, and increased healthcare utilization, and also with a higher prevalence of anxiety, depression, and cardiovascular diseases. Shira is considered as uttamanga, the place where the prana, controls all the activities and all the indriya’s are located. Shiro Pichu is one among the Murdhini taila. Murdhini taila is a chikitsa for Nidranasha. Padaabhyanga is considered as Nidrakrit ,Maruta Upashamana and Ksheerabala taila is Rasayana Mukyatama, Jeevana, Brihmana, Indriyaprasadana and Sukra Asruk dosha nashana effective in curing all 80 types of vata rogas and can be used as Pana, Basti, Nasya and Abhyanga. 

RATIONALE AND NEED FOR STUDY Menopausal women show an increased prevalence of Insomnia for years after diagnosis and treatment. Neglected Insomnia in postmenopausal women will lead to impairment in their work or at home and thus decrease quality of life, memory problems, increase anxiety, depression, and reduced capacity in carrying out day-to-day activities, and also worsen the associated menopausal symptoms. Treatment protocols for Insomnia are mainly Hypnotic drugs and cognitive behavioral therapy. Prolonged use of Hypnotic drugs may result in drug dependence, sleepiness, hangovers in the morning, sleep impairment after discontinuation, and ultimately not cure Insomnia. In this scenario, it becomes more significant to find out the effect of other alternative therapies in managing this condition. Already proven methods are combined and incorporated into the management of Menopausal Insomnia to get better results. In Ayurveda Padaabhyanga and Shiropichu are advised as management for Nidranasha. Ksheerabala taila, the ingredients Ksheera is Jeevaniya, Nidrajanana, Bala (Sida cordifolia) and tila taila has Vata hara properties. In this study, an attempt is made to know the efficacy of Padaabhyanga and Shiropichu with Ksheerabala taila in the management of Menopausal Insomnia. 

 METHODOLOGY 30 patients attending Streeroga & Prasuti Tantra OPD & IPD of Amrita Ayurveda Hospital fulfilling the inclusion criteria will be recruited for the study. After taking informed consent, the procedure of shiro pichu and pada abhyanga will be explained and proper training will be given to the patient and bystander. A Pamphlet and video demonstrating the detailed procedure of shiro pichu and pada abhyanga will be also given to the patient. The patient is advised to do, Shiro pichu 1 hour before sleep with a duration of 30 minutes after that patient is advised to rest for 10 minutes after the procedure. The Duration of Shiropichu is 7 days. Padaabhyanga should be done on each foot for 15 minutes twice daily and advised to take rest for 10 minutes after the procedure. The duration of pada abhyanga is 15 days. Assessment will be done on the 1st Day (D1) - On the day of recruitment, on the 8th Day (D8) - After the completion of Shiro Pichu, and 16th Day (D16) -After the completion of Padaabhyanga. The patient will be advised to report on the 8 th day, the assessment will be done, and also advised to stop Shiropichu and continue Padaabhyanga for 8 days. Assessment criteria used in the study are the Pittsburgh sleep quality Index and Insomnia severity index. •

 DURATION OF STUDY: 15 days
 
Close